A phase I trial of a pharmacodynamically-conceived decitabine/thioguanine combination in patients with advanced myeloid malignancies.Todd Rosenblat, Mark G. Frattini, Hakim Djaballah et al.|Journal of Clinical Oncology|2015Cited by 0